SEARCH OUR PRODUCT CATALOG

AKAP13-NTRK3 Fusion FISH Probe

The AKAP13-NTRK3 Fusion FISH Probe is used to confirm a fusion of the AKAP13 and NTRK3 genes. The fusion of the AKAP13 and NTRK3 genes has been associated with Brain Lower Grade Glioma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
AKAP13-NTRK3-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
AKAP13-NTRK3-20-RERE 20 (40 μL) 200 μL
AKAP13-NTRK3-20-REOR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-REGO 20 (40 μL) 200 μL
AKAP13-NTRK3-20-REGR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-REAQ 20 (40 μL) 200 μL
AKAP13-NTRK3-20-ORRE 20 (40 μL) 200 μL
AKAP13-NTRK3-20-OROR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-ORGO 20 (40 μL) 200 μL
AKAP13-NTRK3-20-ORAQ 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GORE 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GOOR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GOGO 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GOGR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GOAQ 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GRRE 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GROR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GRGO 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GRGR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-GRAQ 20 (40 μL) 200 μL
AKAP13-NTRK3-20-AQRE 20 (40 μL) 200 μL
AKAP13-NTRK3-20-AQOR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-AQGO 20 (40 μL) 200 μL
AKAP13-NTRK3-20-AQGR 20 (40 μL) 200 μL
AKAP13-NTRK3-20-AQAQ 20 (40 μL) 200 μL

NTRK3 Gene Summary

This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]

Gene Name: Neurotrophic Receptor Tyrosine Kinase 3

Chromosome: CHR15: 88419987 -88799962

Locus: 15q25.3

AKAP13 Gene Summary

The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]

Gene Name: A-kinase Anchoring Protein 13

Chromosome: CHR15: 85923870 -86292586

Locus: 15q25.3

Gene Diseases

The AKAP13 NTRK3 Fusion has been associated with the following diseases:

Disease Name
Brain Lower Grade Glioma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Identification of NTRK3 Fusions in Childhood Melanocytic Neoplasms

Our NTRK3 break apart probes were used to detect NTRK3 rearrangements in spitzoid neoplasms, a subtype of melanocytic tumors characterized by an absence of typical melanoma-associated mutations. Four of the patients tested positive for NTRK3 translocations, including a novel MYO5A-NTRK3 fusion.